Iovance Biotherapeutics Insider Trades

IOVA

Track insider trading activity from Iovance Biotherapeutics executives and directors. See which insiders are buying and selling IOVA stock.

Trades Last 12 Months

IOVA Price

All Insider Trades for Iovance Biotherapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Maynard Ryan D Director
Holding Value $355k 90,316 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$364k 90,316 shares
$4.03
$3.93
Weiser Michael Director
Holding Value $355k 90,316 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$364k 90,316 shares
$4.03
$3.93
Dukes Iain D. Director
Holding Value $710k 180,632 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$728k 180,632 shares
$4.03
$3.93
Puri Raj K. Chief Regulatory Officer
Holding Value $59k 15,000 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60.5k 15,000 shares
$4.03
$3.93
Holding Value $355k 90,316 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$364k 90,316 shares
$4.03
$3.93
Bilinsky Igor Chief Operating Officer
Holding Value $526k 133,920 shares
Last Trade
Jun 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.8k 3,976 shares
$4.23
$3.93
Vogt Frederick G Interim CEO & General Counsel
Holding Value $2.21M 562,492 shares
Last Trade
Jun 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$28.1k 6,638 shares
$4.23
$3.93
Graf Finckenstein Friedrich Chief Medical Officer
Holding Value $566k 144,087 shares
Last Trade
Jun 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33k 7,813 shares
$4.23
$3.93
Kirby Daniel Gordon Chief Commercial Officer
Holding Value $275k 70,004 shares
Last Trade
May 11, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$37k 10,000 shares
$3.70
$3.93
Bilinsky Igor Chief Operating Officer
Holding Value $462k 117,500 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$636k 117,500 shares
$5.41
$3.93
Roche Corleen M. Chief Financial Officer
Holding Value $520k 132,200 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$715k 132,200 shares
$5.41
$3.93
Graf Finckenstein Friedrich Chief Medical Officer
Holding Value $231k 58,750 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$318k 58,750 shares
$5.41
$3.93
Rosinack Matthew W. Svp, Finance (int. PFO & Pao)
Holding Value $350k 89,129 shares
Last Trade
Jun 30, 2025 Sale
$129k 75,000 shares
$1.72
$3.93
Weiser Michael Director
Holding Value $265k 67,546 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 67,546 shares
$2.24
$3.93
Yarno Wendy L Director
Holding Value $265k 67,546 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 67,546 shares
$2.24
$3.93
Bellemin Jean Marc Chief Financial Officer
Holding Value $242k 61,528 shares
Last Trade
Jun 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.5k 8,789 shares
$1.76
$3.93
Mcpeak Merrill A Director
Holding Value $197k 50,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$840k 50,000 shares
$16.79
$3.93
Holding Value $393k 100,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.68M 100,000 shares
$16.79
$3.93
Dixon Wendy L Director
Holding Value $201k 51,204 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$425k 51,204 shares
$8.30
$3.93
Fardis Maria President And CEO
Holding Value $983k 250,000 shares
Last Trade
Jan 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.6M 250,000 shares
$46.26
$3.93

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up